UNSPSC 85816206: Introduction of autologous pancreatic islet cells into peripheral vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of autologous pancreatic islet cells into peripheral vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E030U0

UNSPSC 85816206, Introduction of autologous pancreatic islet cells into peripheral vein, open approach, is a Commodity code that does not reflect the actual work state and local governments are procuring under this designation. The recent opportunities posted against this code span virtual urgent care services, medical services contracts, occupational health programs, cancer registry and screening services, employee wellness platforms, psychiatric and psychological evaluations, medical director roles, and clinical staffing—none of which involve pancreatic islet cell transplantation or the specialized endocrinology procedures the code nominally describes. State and local issuing bodies—counties, cities, a health plan, a state health authority, school districts, sheriff's offices, and behavioral health departments—are using this code to tag routine healthcare operations, preventive services, and administrative health functions. The geographic spread spans California, Georgia, Nevada, Colorado, Florida, Arizona, Illinois, New Jersey, Texas, Oregon, and Kansas, with no concentration in any region. Recent representative solicitations include Inland Empire Health Plan requesting 24/7 virtual urgent care services (RFI, due October 31, 2026); Nevada Health Authority soliciting Program of All Inclusive Care for the Elderly (PACE) operations statewide (RFP, due December 10, 2026); San Mateo County requesting cancer registry services for its medical center (RFP, due November 6, 2026); and the County of Santa Clara Health System establishing a qualified vendor list for travel nurse staffing services (due January 6, 2027).

The mismatch between the code's clinical specificity and the breadth of health services actually being procured signals either systematic miscoding by issuing bodies or an artifact of how procurement systems classify health-related opportunities. The code appears to be functioning as a catch-all for state and local healthcare service contracts rather than identifying a specialized transplant procedure line. This creates noise in category analysis and obscures signal about actual transplant-related procurement. Business development professionals should treat this code as unreliable for targeting specific clinical service opportunities and instead focus on scope analysis of individual solicitations rather than relying on the UNSPSC designation as a decision filter.